A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA withdraws emergency use authorization of Eli Lilly’s bebtelovimab injectable COVID-19 antibody therapy, citing the therapy is most likely ineffective against Omicron BQ.1 and BQ.1.1; Lilly had supplied 60,000 doses of the drug to US government in Q3

Sorrento Therapeutics reports its STI-1558 experimental oral COVID-19 drug shows initial signs of efficacy in two early-stage studies; in one study treatment reduced viral RNA load by the third day

Lupin launches formoterol fumarate inhalation solution in US; drug is generic equivalent of Mylan’s Perforomist inhalation solution, which has estimated annual sales of US$268.0M in the US

Nestle mulls options for peanut allergy drug Palforzia after slow adoption by patients, healthcare professionals; Palforzia is only oral immunotherapy approved by FDA to reduce allergic reactions to peanuts

Kyowa Kirin divests 13 mature brands to Grunenthal in deal worth US$83.0M, plus royalties; products include Abstral fentanyl sublingual tablets, PecFent fentanyl nasal spray, Moventig naloxegol, Adcal-D3 calcium and vitamin D3 for osteoporosis

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count